Citi Keeps Their Buy Rating on Eli Lilly & Co (LLY)
In a report released today, Geoff Meacham from Citi maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares ...
Eli Lilly's rating gets an upgrade to Aa3 by Moody's Ratings
Ratings has upgraded the issuer rating and senior unsecured notes ratings of global pharmaceutical company Eli Lilly and ...
STAT13h
Lilly expands GLP-1 research to hypertension, neuro conditions
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...
Eli Lilly price target raised to $1,000 from $997 at BofA
BofA analyst Tim Anderson raised the firm’s price target on Eli Lilly (LLY) to $1,000 from $997 and keeps a Buy rating on the shares after ...
Kiehl’s makes a font out of pubes, Starbucks goes back to basics, and Slice soda returns from the ’80s
This week, skincare brand Kiehl’s debuted a hairy new font, Starbucks continued to roll out its feel-good nostalgia marketing, and an iconic ’80s soda was revived for the year 2025. Here’s all the ...